China has historically been considered a high risk location for multi-national companies. An analysis of publicly available information determined that in the past five years alone, there have been 29 actions by U.S. enforcement agencies alleging FCPA violations involving China.
Entries in Whistleblower (173)
The Securities and Exchange Commission awarded $17 million to a whistleblower Thursday, the second biggest payment since its whistleblower program began nearly five years ago.
A former Genentech product manager who alleged his company exaggerated the effectiveness of the drug Tarceva to treat lung cancer will collect more than $10 million as part of a False Claims Act settlement.
The Securities and Exchange Commission awarded more than $450,000 jointly to two individuals Friday for a tip that led the SEC to open a corporate accounting investigation and for their help once the investigation was underway.
The Securities and Exchange Commission awarded a whistleblower more than $3.5 million Friday for producing evidence against his or her company during an ongoing investigation "that strengthened the SEC's case."
Yesterday, China’s two main judicial agencies released a joint judicial interpretation on bribery, corruption, and misappropriation of official funds.
The U.S. Commodity Futures Trading Commission awarded more than $10 million to a whistleblower last week who provided key original information that led to a successful CFTC enforcement action.
Since the inception of the SEC Whistleblower Program, the agency has paid $57 million in awards to 26 whistleblowers. From the information released by the SEC Office of the Whistleblower, however, none of these awards was based on information about FCPA violations.
The SEC said last week it paid almost $2 million to three whistleblowers. The biggest award -- about $1.8 million -- went to one of the whistleblowers.
The biggest doctor-led cancer care provider in the United States and a Florida subsidiary paid $34.7 million Tuesday to resolve whistleblower allegations they performed and billed for procedures that weren't medically necessary.
The U.S. Securities and Exchange Commission released an Order Determining Whistleblower Award Claim for more than $700,000 to one person, but denying an award to three other claimants for the same matter.